Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Dopaminergic treatment has ‘minor impact’ on autonomic symptoms in Parkinson’s

Norwegian researchers say that dopaminergic treatment should be considered for patients with early Parkinson’s disease after finding that dopaminergic medication only has a minor impact on autonomic symptoms after 1 year.

17 Oct 2012

Extradural brain stimulation safe and effective for patients with Parkinson's

Electrical stimulation using extradural electrodes—placed underneath the skull but not implanted in the brain—is a safe approach with meaningful benefits for patients with Parkinson's disease, reports the October issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

17 Oct 2012

Study finds novel function of non-protein coding RNA

While studying Parkinson's disease, an international research group made a discovery which can improve industrial protein synthesis for therapeutic use. They managed to understand a novel function of non-protein coding RNA: the protein synthesis activity of coding genes can be enhanced by the activity of the non-coding one called "antisense."

17 Oct 2012

Saint Mary's, Mercy Health and VAI sign agreements to expand biorepository

Van Andel Institute (VAI) and two West Michigan hospitals within the national Trinity Health system and members of Mercy Health - Saint Mary's Health Care and Mercy Health Partners - have signed agreements paving the way for the expansion of a world-class biorepository utilizing the infrastructure of the VAI Program for Biospecimen Science.

17 Oct 2012

Antipsychotic drug exposure may have neurologic consequences

French researchers report an increased risk for Parkinson’s disease in elderly people who have past exposure to neuroleptic drugs.

16 Oct 2012

LRRK2 inhibitors may provide neuroprotection for patients with Parkinson's

For decades, patients with Parkinson's disease (PD) have had the same experience. Their hands start to shake uncontrollably, their limbs become rigid and they lose their balance. Years before those movement problems set in, many begin struggling with fainting, incontinence, sexual dysfunction, anxiety and depression. Many patients are still treated with a 42-year-old drug called L-DOPA, which temporarily staves off symptoms but can itself cause heart arrhythmias, stomach bleeding and hallucinations.

16 Oct 2012

Animal research shows promise in treating AD, brain damage and heart problems resulting from SCIs

New animal studies provide additional support for investigating stem cell treatments for Parkinson's disease, head trauma, and dangerous heart problems that accompany spinal cord injury, according to research findings released today.

16 Oct 2012

Maryland scientists create stem cell model for Gaucher disease

A new method of using adult stem cells as a model for the hereditary condition Gaucher disease could help accelerate the discovery of new, more effective therapies for this and other conditions such as Parkinson's, according to new research from the University of Maryland School of Medicine.

16 Oct 2012

Rapamycin may delay onset of Parkinson's or AD

Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's.

16 Oct 2012

New findings on Alzheimer's disease presented at Neuroscience 2012

Curtailing the imminent rise in Alzheimer's disease (AD) will require early, accurate diagnostic tests and treatments, and researchers are closer to achieving these two goals. New findings in medical imaging, molecular analysis of neurological diseases, and development of treatments using mouse models were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

15 Oct 2012

GE Healthcare launches new online patient and caregiver resource for Parkinson's disease

As part of GE Healthcare's ongoing commitment to provide resources for those living with movement disorders, the company announced today a new online patient and caregiver resource - www.Move2Answers.com.

15 Oct 2012

Civitas to present CVT-301 Phase 1 study results at Parkinson's Disease Therapeutics Conference

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, announced today that the Company will make its first public presentation at the Sixth Annual Parkinson's Disease Therapeutics Conference, sponsored by The Michael J. Fox Foundation for Parkinson's Research, to be held on October 24th in New York City.

15 Oct 2012

AAPS recognizes top scientists in pharmaceutical sciences

During the Opening Session of the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, AAPS President David Y. Mitchell, Ph.D., presented the following ground-breaking researchers with awards commemorating their contributions to the pharmaceutical sciences:

15 Oct 2012

$IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls$

IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls

Today, the International Osteoporosis Foundation (IOF) released a new report, revealing approximately 80 percent of patients treated in clinics or hospitals following a fracture are not screened for osteoporosis or risk of future falls. Left untreated, these patients are at high risk of suffering secondary fractures and facing a future of pain, disfigurement, long-term disability and even early death.

12 Oct 2012

Amarantus acquires option to license LymPro Alzheimer's diagnostic blood test from MDx

Amarantus BioSciences, Inc., a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptotis therapeutic protein MANF, today announced that it has acquired an exclusive option to license the LymPro Alzheimer's Diagnostic Blood Test from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, LLC.

11 Oct 2012

Stroke on the rise among young people

New research reveals that stroke may be affecting people at a younger age. The study is published in the October 10, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

11 Oct 2012

EHRs enhance quality of patient care in community-based settings

A new study by Weill Cornell Medical College researchers, published in the Journal of General Internal Medicine, provides compelling evidence that electronic health records (EHRs) enhance the quality of patient care in a community-based setting with multiple payers, which is representative of how medicine is generally practiced across the United States.

10 Oct 2012

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Working with individuals with traumatic brain injury (TBI) every day, I see the debilitating effects and long-term struggles firsthand.

9 Oct 2012

Eating tomatoes associated with reduced risk of stroke

Eating tomatoes and tomato-based foods is associated with a lower risk of stroke, according to new research published in the October 9, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Tomatoes are high in the antioxidant lycopene.

9 Oct 2012

Scripps scientists to study several compounds with potential to improve QOL for ALS patients

A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.

9 Oct 2012

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Dopaminergic treatment has ‘minor impact’ on autonomic symptoms in Parkinson’s

Extradural brain stimulation safe and effective for patients with Parkinson's

Study finds novel function of non-protein coding RNA

Saint Mary's, Mercy Health and VAI sign agreements to expand biorepository

Antipsychotic drug exposure may have neurologic consequences

LRRK2 inhibitors may provide neuroprotection for patients with Parkinson's

Animal research shows promise in treating AD, brain damage and heart problems resulting from SCIs

Maryland scientists create stem cell model for Gaucher disease

Rapamycin may delay onset of Parkinson's or AD

New findings on Alzheimer's disease presented at Neuroscience 2012

GE Healthcare launches new online patient and caregiver resource for Parkinson's disease

Civitas to present CVT-301 Phase 1 study results at Parkinson's Disease Therapeutics Conference

AAPS recognizes top scientists in pharmaceutical sciences

IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls

Amarantus acquires option to license LymPro Alzheimer's diagnostic blood test from MDx

Stroke on the rise among young people

EHRs enhance quality of patient care in community-based settings

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Eating tomatoes associated with reduced risk of stroke

Scripps scientists to study several compounds with potential to improve QOL for ALS patients

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in